Viridian Therapeutics, Inc.\DE (VRDN) Net Margin (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) reported Net Margin of -44760.21% for Q2 2026, up 89553.12 percentage points from -134313.33% a year earlier and up 29637.66 percentage points from the prior quarter.
Viridian Therapeutics, Inc.\DE (VRDN) Net Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Viridian Therapeutics, Inc.\DE's Net Margin came in at -544.06%, up 112262.82 percentage points year-over-year; for FY2025, it came in at -483.57%, up 88903.52 percentage points from FY2024.
- Net Margin has a five-year change of +10060.72 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at -89387.09% in FY2024 (-13675.62 pp), -75711.46% in FY2023 (-68382.23 pp), -7329.23% in FY2022 (-4649.08 pp) and -2680.16% in FY2021 (+7864.13 pp).
- Five-year quarterly Net Margin spans a low of -134313.33% in Q2 2025 and a high of -49.03% in Q3 2025.
- Year over year, Net Margin has now increased in each of the last four quarters, with an average year-over-year change of +13294.74 percentage points over the last eight quarters.
- The high point for year-over-year Net Margin in five years was Q4 2021 (a gain of 154514.57 percentage points); the low point was Q2 2023 (a drop of 64956.47 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -74397.87% (Q1 2026), -91178.03% (Q4 2025) and -49.03% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | -44,760.21% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44,760.21% |
| Mar 31, 2026 | -74,397.87% |
| Dec 31, 2025 | -91,178.03% |
| Sep 30, 2025 | -49.03% |
| Jun 30, 2025 | -134,313.33% |
| Mar 31, 2025 | -120,711.11% |
| Dec 31, 2024 | -110,729.17% |
| Sep 30, 2024 | -89,173.26% |
| Jun 30, 2024 | -90,268.06% |
| Mar 31, 2024 | -67,419.44% |
| Dec 31, 2023 | -92,861.11% |
| Sep 30, 2023 | -66,194.44% |
| Jun 30, 2023 | -76,476.39% |
| Mar 31, 2023 | -69,541.84% |
| Dec 31, 2022 | -43,604.76% |
| Sep 30, 2022 | -2,418.83% |
| Jun 30, 2022 | -11,519.92% |
| Mar 31, 2022 | -11,894.91% |
| Dec 31, 2021 | -13,526.17% |
| Sep 30, 2021 | -6,751.44% |
Viridian Therapeutics, Inc.\DE Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();